STERIS plc (STE) stock
Close on Nov 11, 2026Market cap $24.99BP/E 30.4Yield 0.96%
STERIS plc grew revenue 8.1% to $6.17B over the twelve months to Sep 30, 2026. Operating income rose 20.2% to $1.17B, moving the operating margin from 17.1% to 19.0%. Free cash flow was $937.20M, down 2.5% from a year earlier. At the latest close the market valued the company at $24.99B, 30.4 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $24.99B
- P/E ratio
- 30.4
- Price to sales
- 4.05
- Price to book
- 3.44
- Dividend yield
- 0.96%
- Free cash flow yield
- 3.75%
Fundamentals
- Revenue
- $6.17B
- Net income
- $826.90M
- EPS, diluted
- $8.43
- Free cash flow
- $937.20M
- Book value per share
- $74.36
- Diluted shares
- 98M
Trading
- Next earnings
- Feb 3, 2027 (estimated, after the close)
- Previous close
- $257.12
- Open
- $253.45
- Day's range
- $252.09 – $257.14
- Volume
- 596,642
- Average volume (20 days)
- 870,968
- Index membership
- S&P 500 (since Mar 2020), Russell 1000 (since Sep 2022)
- Beta (5 years)
- 0.75
- 52-week range
- $195.14 – $269.44
- RSI (14 days)
- 74.1
- Volatility (1 year)
- 26.3%
- Relative volume
- 0.82×
- WACC
- 8.3%
Index membership is inferred from the holdings of funds that track each index (VOO, IWB), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | STE | S&P 500 | Difference | STE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.5% | -2.4% | +21.9 pts | ||
| 3 months | +7.9% | -1.2% | +9.1 pts | ||
| Year to date | +2.0% | +12.3% | −10.3 pts | ||
| 1 year | -3.1% | +12.4% | −15.5 pts | ||
| 3 years | +32.3% | +78.8% | −46.6 pts | +9.8% | +21.4% |
| 5 years | +15.9% | +75.2% | −59.2 pts | +3.0% | +11.9% |
| 10 years | +338.3% | +311.1% | +27.2 pts | +15.9% | +15.2% |
Eleven years at a glance
Fiscal years 2016 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Steris filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Steris
Orthopedic, Prosthetic & Surgical Appliances & Supplies
STERIS supplies infection prevention, contamination control, and surgical care products and services worldwide. The company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Healthcare provides infection prevention consumables, surgical tables, automated reprocessing units, washers, sterilizers, endoscopy accessories, and equipment repair and outsourced sterile processing. AST offers contract sterilization modalities, laboratory testing, and automated sterilization machinery and control systems. Life Sciences supplies pharmaceutical detergents, cleanroom disinfectants, sterilizers, vaporized hydrogen peroxide room decontamination systems, and high-purity water generators. Its customer base includes healthcare providers, hospitals, endoscopy and ambulatory surgery centers, and pharmaceutical and medical device manufacturers.
Company profile, executives and historySteris stock: common questions
What is Steris's stock price?
STE closed at $256.27 on Nov 11, 2026, down 0.33% on the day. Over the past 52 weeks it traded between $195.14 and $269.44.
What is Steris's market cap?
Steris was worth $24.99B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is STE's P/E ratio?
STE trades at 30.4 times earnings, based on diluted earnings per share of $8.43 over the twelve months to Sep 30, 2026.
How much revenue does Steris make?
Steris reported revenue of $6.17B for the twelve months to Sep 30, 2026, up 8.1% from a year earlier.
Does Steris pay a dividend?
Yes. Steris paid $2.46 per share over the last twelve months, a yield of 0.96% at the latest price, and has raised its annual dividend 9 years in a row.
When does Steris report earnings next?
Steris is expected to report Q3 FY2027 results on Feb 3, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has STE stock performed over the past year?
Including dividends, STE returned -3.1% over the past year, against +12.4% for the S&P 500.
How many STE shares are sold short?
2M shares were sold short at the latest FINRA report, 2.24% of the float, or 2.9 days of average trading volume.
Who are Steris's competitors?
Companies most similar to Steris by business, industry and size include SNN, ISRG, EW, SOLV, BAX.
See a number that looks wrong?